Ingrid Øra
81 – 90 of 103
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Low frequency of EWSR1 rearrangements in neoplasms classified as high-risk wilms tumors.
(
- Contribution to journal › Article
-
Mark
High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
(
- Contribution to journal › Article
- 2008
-
Mark
High levels of HIF-2alpha highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche.
(
- Contribution to journal › Article
-
Mark
The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is'-down-regulated by MYCN
(
- Contribution to journal › Article
-
Mark
mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis
(
- Contribution to journal › Article
-
Mark
High-resolution molecular cytogenetic analysis of Wilms tumors highlights diagnostic difficulties among small round cell kidney tumors.
(
- Contribution to journal › Article
- 2007
-
Mark
Concurrent gain of 17q and the MYC oncogene in a medullomyoblastoma
(
- Contribution to journal › Article
-
Mark
Defective chromosome segregation and telomere dysfunction in aggressive Wilms' tumors
(
- Contribution to journal › Article
-
Mark
Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukaemias.
(
- Contribution to journal › Article